Alkem Laboratories
Alkem Laboratories Limited, a prominent player in the pharmaceutical industry, is headquartered in Mumbai, India. Founded in 1973, the company has established a strong presence in various operational regions, including North America, Europe, and Asia. Alkem is renowned for its extensive portfolio of generic and branded formulations, as well as active pharmaceutical ingredients (APIs), catering to diverse therapeutic areas such as anti-infectives, cardiology, and gastroenterology. With a commitment to quality and innovation, Alkem Laboratories has achieved significant milestones, including numerous approvals from regulatory authorities worldwide. The company is recognised for its robust research and development capabilities, which underpin its unique product offerings. Alkem's market position is further solidified by its consistent growth and notable achievements, making it a trusted name in the global healthcare landscape.
DitchCarbon Score
How does Alkem Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alkem Laboratories's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alkem Laboratories's reported carbon emissions
In 2024, Alkem Laboratories reported total carbon emissions of approximately 101,568,000 kg CO2e, comprising 19,249,000 kg CO2e from Scope 1 and 82,319,000 kg CO2e from Scope 2 emissions. This data reflects a consistent emission profile over the previous years, with similar figures reported in 2023 and 2022, indicating a stable operational footprint. For 2023, Alkem Laboratories again recorded total emissions of about 101,568,000 kg CO2e, with Scope 1 emissions at 19,249,000 kg CO2e and Scope 2 emissions at 82,319,000 kg CO2e. In 2022, the total emissions were approximately 94,274,000 kg CO2e, with Scope 1 at 15,773,000 kg CO2e and Scope 2 at 78,502,000 kg CO2e. This shows a slight increase in emissions from 2022 to 2023, but the figures remained consistent in 2024. Alkem Laboratories has not set specific reduction targets or climate pledges, nor do they report any initiatives under the Science Based Targets initiative (SBTi). The company has disclosed emissions data for Scope 1 and Scope 2 but has not provided information on Scope 3 emissions. Overall, Alkem Laboratories maintains a significant carbon footprint, with a focus on transparency in their emissions reporting, but lacks defined reduction strategies or commitments to lower their environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 15,773,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 78,502,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Alkem Laboratories is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
